Observational Safety Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus

Trial Profile

Observational Safety Study in Subjects Using Levemir (Insulin Detemir) for the Treatment of Type 2 Diabetes Mellitus

Completed
Phase of Trial: Phase IV

Latest Information Update: 03 Nov 2016

At a glance

  • Drugs Insulin detemir (Primary)
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions
  • Acronyms LevSafeQD
  • Sponsors Novo Nordisk
  • Most Recent Events

    • 15 Jan 2010 Actual patient number (747) added as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 15 Jan 2010 Actual end date (October 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top